Oncolytic Herpes Simplex Virus-Based Therapies for Cancer

With the increased worldwide burden of cancer, including aggressive and resistant cancers, oncolytic virotherapy has emerged as a viable therapeutic option. Oncolytic herpes simplex virus (oHSV) can be genetically engineered to target cancer cells while sparing normal cells. This leads to the direct...

Descripción completa

Detalles Bibliográficos
Autores principales: Aldrak, Norah, Alsaab, Sarah, Algethami, Aliyah, Bhere, Deepak, Wakimoto, Hiroaki, Shah, Khalid, Alomary, Mohammad N., Zaidan, Nada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235327/
https://www.ncbi.nlm.nih.gov/pubmed/34207386
http://dx.doi.org/10.3390/cells10061541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235327/
https://www.ncbi.nlm.nih.gov/pubmed/34207386
http://dx.doi.org/10.3390/cells10061541

Ejemplares similares